These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28978803)

  • 1. Involvement of the metabolic sensor GPR81 in cardiovascular control.
    Wallenius K; Thalén P; Björkman JA; Johannesson P; Wiseman J; Böttcher G; Fjellström O; Oakes ND
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing.
    Sakurai T; Davenport R; Stafford S; Grosse J; Ogawa K; Cameron J; Parton L; Sykes A; Mack S; Bousba S; Parmar A; Harrison D; Dickson L; Leveridge M; Matsui J; Barnes M
    Eur J Pharmacol; 2014 Mar; 727():1-7. PubMed ID: 24486398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 Mediates the Systemic and Renal Hemodynamic Effects of GPR81 Activation.
    Jones NK; Stewart K; Czopek A; Menzies RI; Thomson A; Moran CM; Cairns C; Conway BR; Denby L; Livingstone DEW; Wiseman J; Hadoke PW; Webb DJ; Dhaun N; Dear JW; Mullins JJ; Bailey MA
    Hypertension; 2020 May; 75(5):1213-1222. PubMed ID: 32200679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81.
    Liu C; Wu J; Zhu J; Kuei C; Yu J; Shelton J; Sutton SW; Li X; Yun SJ; Mirzadegan T; Mazur C; Kamme F; Lovenberg TW
    J Biol Chem; 2009 Jan; 284(5):2811-2822. PubMed ID: 19047060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81.
    Ahmed K; Tunaru S; Tang C; Müller M; Gille A; Sassmann A; Hanson J; Offermanns S
    Cell Metab; 2010 Apr; 11(4):311-9. PubMed ID: 20374963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of GPR81 in lactate-mediated reduction of adipose lipolysis.
    Cai TQ; Ren N; Jin L; Cheng K; Kash S; Chen R; Wright SD; Taggart AK; Waters MG
    Biochem Biophys Res Commun; 2008 Dec; 377(3):987-91. PubMed ID: 18952058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpressing cell systems are a competitive option to primary adipocytes when predicting in vivo potency of dual GPR81/GPR109A agonists.
    Almquist J; Hovdal D; Ahlström C; Fjellström O; Gennemark P; Sundqvist M
    Eur J Pharm Sci; 2018 Mar; 114():155-165. PubMed ID: 29180298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids.
    Ge H; Li X; Weiszmann J; Wang P; Baribault H; Chen JL; Tian H; Li Y
    Endocrinology; 2008 Sep; 149(9):4519-26. PubMed ID: 18499755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelin responsiveness and receptor characteristics in vitro and effects of endothelin receptor blockade in vivo in cyclosporin hypertension.
    Phillips PA; Rolls KA; Burrell LM; Casley D; Aldred KL; Hardy KJ
    Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):223-6. PubMed ID: 8076426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of new hypoglycemic agent A-4166 on lipolysis and lipogenesis in rat adipocytes.
    Macho L; Fickova M; Zorad S; Sebokova E; Klimes I
    Endocr Regul; 2000 Sep; 34(3):119-26. PubMed ID: 11074662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate receptor sites link neurotransmission, neurovascular coupling, and brain energy metabolism.
    Lauritzen KH; Morland C; Puchades M; Holm-Hansen S; Hagelin EM; Lauritzen F; Attramadal H; Storm-Mathisen J; Gjedde A; Bergersen LH
    Cereb Cortex; 2014 Oct; 24(10):2784-95. PubMed ID: 23696276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV attenuates lipolysis and improves insulin resistance induced by TNFalpha in 3T3-L1 adipocytes.
    Jiang B; Yang Y; Jin H; Shang W; Zhou L; Qian L; Chen M
    Phytother Res; 2008 Nov; 22(11):1434-9. PubMed ID: 18972582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of signaling and functional activities of an orphan GPCR, GPR81.
    Ge H; Weiszmann J; Reagan JD; Gupte J; Baribault H; Gyuris T; Chen JL; Tian H; Li Y
    J Lipid Res; 2008 Apr; 49(4):797-803. PubMed ID: 18174606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,5-Dihydroxybenzoic acid, a specific agonist for hydroxycarboxylic acid 1, inhibits lipolysis in adipocytes.
    Liu C; Kuei C; Zhu J; Yu J; Zhang L; Shih A; Mirzadegan T; Shelton J; Sutton S; Connelly MA; Lee G; Carruthers N; Wu J; Lovenberg TW
    J Pharmacol Exp Ther; 2012 Jun; 341(3):794-801. PubMed ID: 22434674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of G protein-coupled receptor 81 (GPR81) protects against ischemic brain injury.
    Shen Z; Jiang L; Yuan Y; Deng T; Zheng YR; Zhao YY; Li WL; Wu JY; Gao JQ; Hu WW; Zhang XN; Chen Z
    CNS Neurosci Ther; 2015 Mar; 21(3):271-9. PubMed ID: 25495836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endothelin in the control of peripheral vascular tone in human hypertension.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Magagna A; Salvetti A
    Heart Fail Rev; 2001 Dec; 6(4):277-85. PubMed ID: 11447302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Properties of Lactate in Müller Cells: The Effect of GPR81 Activation.
    Vohra R; Aldana BI; Waagepetersen H; Bergersen LH; Kolko M
    Invest Ophthalmol Vis Sci; 2019 Mar; 60(4):999-1008. PubMed ID: 30884529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel peptide targeting GPR81 to suppress adipocyte-mediated tumor progression.
    Chen S; Zhou X; Li W; Yang X; Niu X; Hu Z; Li S; Chen G; Sui X; Liu J; Gao Y
    Biochem Pharmacol; 2023 Nov; 217():115800. PubMed ID: 37696459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate produced during labor modulates uterine inflammation via GPR81 (HCA
    Madaan A; Nadeau-Vallée M; Rivera JC; Obari D; Hou X; Sierra EM; Girard S; Olson DM; Chemtob S
    Am J Obstet Gynecol; 2017 Jan; 216(1):60.e1-60.e17. PubMed ID: 27615440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid.
    Dhalla AK; Santikul M; Smith M; Wong MY; Shryock JC; Belardinelli L
    J Pharmacol Exp Ther; 2007 Apr; 321(1):327-33. PubMed ID: 17204748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.